2017
DOI: 10.1093/ndt/gfw299
|View full text |Cite
|
Sign up to set email alerts
|

Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis

Abstract: While complement activation is noted in AAV, the complement activation appears to be more prominent in the ANCA-negative glomerulonephritis. The larger amount of C3 and moderate amount of C9 in the ANCA-negative glomerulonephritis implies activation of the alternate and terminal pathway of complement, suggesting that this entity may be caused or promoted by a genetic or acquired defect in the alternative pathway.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
30
0
3

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(36 citation statements)
references
References 40 publications
3
30
0
3
Order By: Relevance
“…The complement activation products were detected in kidneys of patients with AAV, even in ANCAnegative AAV patients [4][5][6][7]22]. The complement system was regulated strictly in the normal state.…”
Section: Discussionmentioning
confidence: 97%
“…The complement activation products were detected in kidneys of patients with AAV, even in ANCAnegative AAV patients [4][5][6][7]22]. The complement system was regulated strictly in the normal state.…”
Section: Discussionmentioning
confidence: 97%
“…The complement activation system is composed of three pathways: the classical pathway, the alternative pathway, and the MBL pathway. Evidence from in vivo and in vitro studies have suggested that the alternative pathway plays a crucial role in the development of AAV . Sugimoto et al illuminated that polyethylene glycol‐precipitated immune complexes from IgG4‐RD patients could activate both the classical and the MBL pathways, although the mechanism has not been clarified.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that the LCMS/MS analysis can be used to detect these amyloid proteins in familial and hereditary amyloidosis, such as transthyretin (ATTR), leukocyte chemotactic factor 2 (LECT2), fibrinogen Aα chain, and apolipoproteinA-I, A-II, and A-IV, which are otherwise difficult to diagnose when using routine pathological techniques [18][19][20]. Moreover, the LCMS/MS proteomic analysis has also been recently utilized to define the glomerular proteomic profile of various types of glomerulonephritis [21,22].…”
Section: Discussionmentioning
confidence: 99%